Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faricimab in Treatment-Naïve Patients With Diabetic Macular Edema (ALTIMETER)
NCT04597918Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of faricimab in diabetic macular edema (DME), sponsored by Roche. Started Nov 2020; status: completed.
02
Drugs
faricimab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04597918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597918.